FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (2281 ms)

ValueSets, Authority National

1499 resources

Source:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

By Version

By realm

Prev Rows 200 - 400 Next
PackageVersionIdentityName/TitleStatusDateRealmSource(s)
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-pancreas-topography NZ cancer gastroenteropancreatic neuroendocrine tumour pancreas topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-stomach-topography NZ cancer gastroenteropancreatic neuroendocrine tumour stomach topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gep-net-topography NZ cancer gastroenteropancreatic neuroendocrine tumour topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-german-hodgkin-stage NZ cancer GHSG Hodgkin treatment stratification stageactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colon-topography NZ cancer gastrointestinal colon topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-colorectal-topography NZ cancer gastrointestinal colorectal topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-duodenum-topography NZ cancer gastrointestinal duodenum topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-exocrine-pancreas-topography NZ cancer gastrointestinal exocrine pancreas topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-jejunum-ileum-topography NZ cancer gastrointestinal ileum and jejunum topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-liver-topography NZ cancer gastrointestinal liver topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-oesophagus-topography NZ cancer gastrointestinal oesophagus topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-pancreas-topography NZ cancer gastrointestinal pancreas topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-rectum-topography NZ cancer gastrointestinal rectum topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-stomach-topography NZ cancer gastrointestinal stomach topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-gi-upper-topography NZ cancer upper gastrointestinal topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grade NZ cancer gradeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grading-system NZ cancer grading systemactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haem-recurrence-type NZ cancer heamatology recurrence typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-stream NZ cancer haematology streamactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-substream NZ cancer haematology substreamactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-haematology-treatment-intent NZ cancer haematology treatment intentactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-cancer-type NZ cancer head and neck cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-hypopharynx-topography NZ cancer head and neck hypopharynx topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-larynx-topography NZ cancer head and neck larynx topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-paranasal-topography NZ cancer head and neck nasal cavity and paranasal sinus topographyactive2024-08sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasal-topography NZ cancer head and neck nasal topographyactive2024-08sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-nasopharynx-topography NZ cancer head and neck nasopharynx topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-odontogenic-topography NZ cancer head and neck odontogenic topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-other-topography NZ cancer head and neck other topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-salivary-gland-topography NZ cancer head and neck major salivary gland topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-substream NZ cancer head and neck substreamactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-head-neck-with-thyroid-topography NZ cancer head and neck with thyroid topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-health-worker-role-path-radio-surg NZ cancer health worker role pathologist radiologist surgeonactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-other-topography NZ cancer other gastrointestinal hepatopancreaticobiliary topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hep-pan-bil-topography NZ cancer gastrointestinal hepatopancreaticobiliary topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-high-level-topography NZ cancer high level topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-hl-ips-prognostic-score NZ cancer Hodgkin lymphoma International Prognostic Scoreactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ipss-r-prognostic-score NZ cancer IPSS-R for MDS prognostic scoreactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-mandatory NZ cancer laterality mandatoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-optional NZ cancer laterality optionalactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-or-side NZ cancer laterality or side retired2024-06sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-side-mandatory NZ cancer laterality or side mandatoryactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality-with-unknown NZ cancer laterality with unknown valueactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-laterality NZ cancer lateralityactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lower-gastro-cancer-type NZ cancer lower gastrointestinal cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lugano-lymphoma-stage NZ cancer Lugano staging classification for lymphomaactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lung-cancer-type NZ lung cancer typeretired2024-08sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymph-node-specimen-type NZ cancer lymph node specimen typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-breast NZ cancer breast lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-eye-orbit NZ cancer eye and orbit lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-cervix-uteri NZ cancer female genital cervix uteri lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-corpus-uteri NZ cancer female genital corpus uteri lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-female-genital-vulva NZ cancer female genital vulva lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-anus NZ cancer gastrointestinal anus lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-colorectal NZ cancer gastrointestinal colorectal lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal-stomach NZ cancer gastrointestinal stomach lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-gastrointestinal NZ cancer gastrointestinal lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-head-neck NZ cancer head and neck lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-male-genital NZ cancer male genital lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax-lung NZ cancer thorax lung lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-thorax NZ cancer thorax lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-kidney NZ cancer urinary and male genital kidney lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-penis NZ cancer urinary and male genital penis lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis-ureter NZ cancer urinary and male genital renal pelvis and ureter lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis NZ cancer urinary and male genital renal pelvis lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-testis NZ cancer urinary and male genital testis lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital-urinary-bladder NZ cancer urinary and male genital urinary bladder lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary-male-genital NZ cancer urinary and male genital lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphnode-urinary NZ cancer urinary system lymph nodeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-lymphoma-substream NZ cancer lymphoma substreamretired2024-05sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-sact-cancer-type NZ cancer male genital SACT cancer typeretired2024-08sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-male-genital-topography NZ cancer male genital topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-malt-ipi-prognostic-score NZ cancer MALT-IPI prognostic scoreactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mastocytosis-cancer-type NZ cancer mastocytosis cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-md-anderson-residual-cancer-burden NZ cancer MD Anderson residual cancer burdenactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mds-myeloproliferative-cancer-type NZ cancer myelodysplastic-myeloproliferative cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cancer-type NZ cancer melanoma cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-melanoma-cns-topography NZ cancer CNS melanoma topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-menopause-status NZ cancer menopause statusactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-non-symmetrical-topography NZ cancer midline non-symmetrical topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-midline-topography NZ cancer midline topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipi-prognostic-score NZ cancer MIPI prognostic scoreactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mipss-70-v2-prognostic-score NZ cancer MIPSS 70+ v2.0 myelofibrosis prognostic scoreactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-cns-cancer-type NZ cancer medical oncology cns cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-cancer-type NZ cancer medical oncology endocrine cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-endocrine-neuroendocrine-cancer-type NZ medical oncology cancer endocrine and neuroendocrine cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-genitourinary-cancer-type NZ cancer medical oncology genitourinary cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-gynaecological-cancer-type NZ cancer medical oncology gynaecological cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-cancer-type NZ cancer medical oncology head and neck cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-cancer-type NZ cancer medical oncology other head and neck cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-head-neck-other-topography NZ cancer medical oncology head and neck other topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-male-genital-topography NZ cancer medical oncology male genital topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-melanoma-topography NZ cancer medical oncology skin and/or melanoma topographyactive2024-09sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-skin-topography NZ cancer medical oncology skin topographyactive2024-09sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-cancer-type NZ cancer medical oncology solid tumour cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-solid-tumour-substream NZ cancer medical oncology solid tumour substreamactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-cancer-type NZ cancer medical oncology thoracic cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thoracic-substream NZ cancer medicial oncology thoracic substreamactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-mesothelioma-topography NZ cancer thorax medical oncology mesothelioma topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-thorax-topography NZ cancer thorax medical oncology topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-treatment-intent NZ cancer medical oncology treatment intentactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-testicular-topography NZ cancer medical oncology urinary and male genital testicular topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-urinary-male-genital-topography NZ cancer medical oncology urinary and male genital topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-mo-who-brain-primary-histology NZ medical oncology WHO brain primary histologyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-moh-refcrit-colonoscopy-2w draft2024-11
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-myeloid-cancer-type NZ cancer myeloid proliferation and myeloid neoplasm cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nail-topography NZ cancer nail topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nasal-paranasal-cancer-type NZ cancer nasal cavity and paranasal sinus cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-benign-reactive-diagnosis NZ cancer national cervical screening programme benign and reactive diagnosisactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-excision-completeness NZ cancer national cervical screening programme completeness of excisionactive2024-09sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-specimen-type NZ cancer national cervical screening programme specimen typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-national-cervical-screening-topography NZ cancer national cervical screening programme topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-response-system NZ cancer neoadjuvant therapy response systemactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neoadjuvant-therapy-type-non-hormone NZ cancer neoadjuvant therapy administration type (non-hormone)active2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-breast-topography NZ cancer neuroendocrine tumour breast topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-male-genital-topography NZ cancer neuroendocrine tumour male genital topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-net-urinary-topography NZ cancer neuroendocrine tumour urinary topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-gep-cancer-type NZ cancer neuroendocrine GEP cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-non-gep-cancer-type NZ cancer neuroendocrine non GEP cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-neuroendocrine-substream NZ cancer neuroendocrine substreamretired2024-05sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-ajcc-staging-system NZ cancer non-AJCC staging systemactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-hodgkin-lymphoma-cancer-type NZ cancer non Hodgkin lymphoma cancer typeretired2024-05sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-non-prostate-genitourinary-cancer-type NZ cancer genitourinary (non prostate) cancer typeretired2024-05sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-not-performed-reason NZ cancer not performed reasonactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nottingham-grade NZ Nottingham Combined gradeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-nuclear-grade NZ cancer nuclear grade of DCIS gradeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-observation NZ cancer observation codeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-parathryoid-topography NZ cancer parathryoid topographyretired2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-percist-1-cancer-burden NZ cancer PERCIST 1.0 cancer burdenactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-performance-status NZ cancer performance statusactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pharynx-larynx-cancer-type NZ cancer pharynx and larynx and trachea cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pit-prognostic-score NZ cancer PIT prognostic scoreactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pituitary-net-topography NZ cancer pituitary neuroendocrine tumour topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-polyp-morphology-specimen-type NZ cancer polyp morphology specimen typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-pos-neg-result NZ cancer positive negative resultactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-presence-tumour-finding NZ cancer presence of tumour findingactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-procedure-status NZ cancer procedure statusactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-prognostic-scoring-system NZ cancer prognostic scoring systemactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-radiology-type NZ cancer radiology typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-rai-cll-stage NZ cancer Rai staging for CLL stageactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recist-1-1-cancer-burden NZ cancer RECIST 1.1 cancer burdenactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-recurrence-type NZ cancer recurrence typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-referral-criteria-procedure-assessment NZ cancer procedure referral criteria assessmentactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-mayo-amyloidosis-stage NZ cancer revised Mayo staging 2012 for AL (amyloidosis) stageactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-revised-multiple-myeloma-stage NZ cancer R-ISS for multiple myeloma stageactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-beam-energy-type NZ cancer radiation oncology beam energy typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-ro-planning-technique NZ cancer radiation oncology planning techniqueactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-aml-disease-response NZ SACT acute myeloid leukemia disease responseactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-amyloidosis-disease-response NZ SACT amyloidosis disease responseactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-substream NZ systemtic anti-cancer therapy substreamactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cancer-type NZ SACT cancer typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cll-sll-disease-response NZ SACT chronic lymphocytic leukemia and small lymphocytic lymphoma disease responseactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-cml-disease-response NZ SACT chronic myeloid leukemia disease responseactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-form NZ SACT dose formactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-dose-unit NZ SACT dose unitactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-ecog-status NZ SACT ECOG statusactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-haem-disease-response NZ SACT haematology disease responseactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-heam-disease-response NZ SACT heamatology disease responseretired2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mds-disease-response NZ SACT myelodysplastic syndrome disease responseactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-mo-disease-response NZ SACT medical oncology disease responseactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-non-small-lymphocytic-disease-response NZ SACT lymphoma (non small lymphocytic) disease responseactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-overall-discontinue-reason NZ SACT overall discontinue reasonactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-patient-factor-discontinue-reason NZ SACT patient factor discontinueactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-pr-expression NZ SACT PR expressionactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-sact-toxicity-discontinue-reason NZ systemic anti-cancer therapy toxicity discontinue reasonactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side-mandatory NZ cancer side mandatoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-side NZ cancer sideactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-simple-performance-status NZ cancer simple performance statusactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-cancer-type NZ cancer skin cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-extremity-topography NZ cancer skin of extremity topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-head-neck-topography NZ cancer skin of head and neck topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-melanoma-substream NZ cancer skin and melanoma substreamactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-topography NZ cancer skin topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-skin-trunk-topography NZ cancer skin of trunk topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-abdomen-pelvis-topography NZ cancer soft tissue abdomen and pelvis topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-cancer-type NZ cancer soft tissue and bone cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-bone-substream NZ cancer soft tissue and bone substreamactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-extremity-topography NZ cancer soft tissue extremity topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-head-neck-topography NZ cancer soft tissue head and neck topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-skin-topography NZ cancer soft tissue skin topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-soft-tissue-thoracic-topography NZ cancer soft tissue thoracic topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-non-ajcc-staging-system NZ cancer solid tumour non-AJCC staging systemactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-sact-cancer-type NZ cancer solid tumour SACT cancer typeretired2024-08sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-staging-system NZ cancer solid tumour staging systemactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-solid-tumour-substream NZ cancer solid tumour substreamactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category-excision-biopsy NZ cancer specimen category biopsy or excisionactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-category NZ cancer specimen categoryactive2024-09sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-colorectal-screening-colonoscopy-type NZ cancer colorectal screening colonoscopy specimen typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-dimension-type NZ cancer specimen dimension typeactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-specimen-polyp-profile NZ cancer polyp profile typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-stage-classification NZ cancer stage classificationactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-intent NZ surgical intentactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-proximal-distal NZ cancer surgical margin qualifier proximal or distalactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-surgical-margin-type NZ cancer surgical margin typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-t-nk-cell-lymphoma-cancer-type NZ cancer T/NK cell lymphoma cancer typeretired2024-05sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-failure-reason NZ cancer test failure reasonactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-test-inconclusive-reason NZ cancer test inconclusive reasonactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thoracic-cancer-type NZ cancer thoracic cancer typeactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-lung-lobe-topography NZ cancer thorax lung lobe topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-soft-tissue-topography NZ cancer thorax soft tissue topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-thymus-topography NZ cancer thorax thymus topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thorax-topography NZ cancer thorax topographyactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thryoid-topography NZ cancer thryoid topographyretired2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-thyroid-topography NZ cancer thyroid topographyactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-b-lymphoma-stage NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stageactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-clinical-stage-group NZ AJCC breast clinical stage groupretired2024-08sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-cm NZ AJCC breast clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-ct NZ AJCC breast clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pathological-stage-group NZ AJCC breast pathological stage groupretired2024-08sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pn NZ AJCC breast pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-pt NZ AJCC breast pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-breast-stage-group NZ AJCC breast stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-clinical-stage-group NZ AJCC clinical stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-cm NZ AJCC clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-gen-corpus-uteri-leiomyosarcoma-stage-group NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-cm NZ AJCC female genital cervix uteri clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-ct NZ AJCC female genital cervix uteri clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pm NZ AJCC female genital cervix uteri pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-pt NZ AJCC female genital cervix uteri pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-cervix-uteri-stage-group NZ AJCC female genital cervix uteri stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-cn NZ AJCC female genital corpus uteri adenosarcoma clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-pt NZ AJCC female genital corpus uteri adenosarcoma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-cn NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-ct NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pt NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-stage-group NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-cm NZ AJCC female genital corpus uteri clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-cn NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-ct NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pt NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pm NZ AJCC female genital corpus uteri pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pn NZ AJCC female genital corpus uteri pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-pt NZ AJCC female genital corpus uteri pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-corpus-uteri-stage-group NZ AJCC female genital corpus uteri stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ct NZ AJCC female genital clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-pm NZ AJCC female genital gestational trophoblastic disease pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-gestational-stage-group NZ AJCC female genital gestational trophoblastic disease stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-cm NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pt NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-pm NZ AJCC female genital pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-cn NZ AJCC female genital vagina clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pm NZ AJCC female genital vagina pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pn NZ AJCC female genital vagina pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-pt NZ AJCC female genital vagina pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vagina-stage-group NZ AJCC female genital vagina stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-ct NZ AJCC female genital vulva clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pm NZ AJCC female genital vulva pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pn NZ AJCC female genital vulva pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-female-genital-vulva-pt NZ AJCC female genital vulva pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-clinical-stage-group NZ AJCC gastrointestinal clinical stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-cn NZ AJCC gastrointestinal clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cm NZ AJCC gastrointestinal colon and rectum clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-cn NZ AJCC gastrointestinal colon and rectum clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-ct NZ AJCC gastrointestinal colon and rectum clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-pn NZ AJCC gastrointestinal colon and rectum pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-colorectal-stage-group NZ AJCC gastrointestinal colon and rectum stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-pn NZ AJCC gastrointestinal pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gi-yp-stage-group NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cm NZ AJCC gastrointestinal stromal tumour clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-cn NZ AJCC gastrointestinal stromal tumour clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-ct NZ AJCC gastrointestinal stromal tumour clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-other-stage-group NZ AJCC gastrointestinal stromal tumour small intestine and oesophageal and colon and rectum and mesenteric and peritoneal stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pm NZ AJCC gastrointestinal stromal tumour pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-gist-pn NZ AJCC gastrointestinal stromal tumour pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cll-or-sll-stage-group NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-cn NZ AJCC haematology clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-hl-or-nhl-stage-group NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cm NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-cn NZ AJCC haematology mycosis fungoides or sezary syndrome clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-ct NZ AJCC haematology mycosis fungoides or sezary syndrome clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pm NZ AJCC haematology mycosis fungoides or sezary syndrome pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pn NZ AJCC haematology mycosis fungoides or sezary syndrome pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-mf-or-ss-pt NZ AJCC haematology mycosis fungoides or sezary syndrome pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-cm NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-ct NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-non-mf-or-ss-pm NZ AJCC haematology cutaneous B cell or T cell non Mycosis fungoides and non-sezary syndrome lymphoma pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-paed-hl-stage-group NZ AJCC haematology pediatric Hodgkin lymphoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pn NZ AJCC haematology pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-haematology-pt NZ AJCC haematology pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-cm NZ AJCC neuroendocrine gastrointestinal colon and rectum clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-pt NZ AJCC neuroendocrine gastrointestinal colon and rectum pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-stage-group NZ AJCC neuroendocrine gastrointestinal colon and rectum stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-ct NZ AJCC neuroendocrine gastrointestinal clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pm NZ AJCC neuroendocrine gastrointestinal pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-pn NZ AJCC neuroendocrine gastrointestinal pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-neuroendocrine-gi-stage-group NZ AJCC neuroendocrine gastrointestinal stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pathological-stage-group NZ AJCC pathological stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pm NZ AJCC pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-pt NZ AJCC pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rcn NZ AJCC recurrence or retreatment clinical N category (rcN)active2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-rpn NZ AJCC recurrence or retreatment pathological N category (rpN)active2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-classification NZ TNM stage classificationactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-stage-clinical-classification NZ clinical TNM stage classificationactive2024-10sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-suffix NZ TNM suffixactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-cn NZ AJCC thoracic clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-ct NZ AJCC thoracic clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cm NZ AJCC thoracic lung clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-cn NZ AJCC thoracic lung clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-lung-stage-group NZ AJCC thoracic lung stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-cn NZ AJCC thoracic malignant pleural mesothelioma clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pm NZ AJCC thoracic malignant pleural mesothelioma pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pn NZ AJCC thoracic malignant pleural mesothelioma pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-pt NZ AJCC thoracic malignant pleural mesothelioma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pleural-stage-group NZ AJCC thoracic malignant pleural mesothelioma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-pn NZ AJCC thoracic pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-stage-group NZ AJCC thoracic stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cm NZ AJCC thoracic thymus clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-cn NZ AJCC thoracic thymus clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-ct NZ AJCC thoracic thymus clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-pt NZ AJCC thoracic thymus pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-thoracic-thymus-stage-group NZ AJCC thoracic thymus stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm-ypn NZ AJCC post therapy (neoadjuvant) pathological N category (ypN)active2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-clinical-stage-group NZ AJCC (8th edition) breast clinical stage groupretired2024-05sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-cn NZ AJCC (8th edition) breast clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-ct NZ AJCC (8th edition) breast clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pn NZ AJCC (8th edition) breast pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-breast-pt NZ AJCC (8th edition) breast pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-gen-ovary-fallopian-peritoneal-stage-group NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-cm NZ AJCC (8th edition) female genital cervix uteri clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-pt NZ AJCC (8th edition) female genital cervix uteri pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cervix-uteri-stage-group NZ AJCC (8th edition) female genital cervix uteri stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-cn NZ AJCC (8th edition) female genital clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-ct NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-pt NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-ct NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-stage-group NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-cn NZ AJCC (8th edition) female genital corpus uteri clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-cn NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-ct NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-pt NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pn NZ AJCC (8th edition) female genital corpus uteri pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-pt NZ AJCC (8th edition) female genital corpus uteri pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-corpus-uteri-stage-group NZ AJCC (8th edition) female genital corpus uteri stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ct NZ AJCC (8th edition) female genital clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-pm NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-gestational-stage-group NZ AJCC (8th edition) female genital gestational trophoblastic disease stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-cm NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-ct NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pm NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pn NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pm NZ AJCC (8th edition) female genital pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-pt NZ AJCC (8th edition) female genital pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-stage-group NZ AJCC (8th edition) female genital stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pm NZ AJCC (8th edition) female genital vagina pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-pt NZ AJCC (8th edition) female genital vagina pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vagina-stage-group NZ AJCC (8th edition) female genital vagina stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cm NZ AJCC (8th edition) female genital vulva clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-cn NZ AJCC (8th edition) female genital vulva clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pm NZ AJCC (8th edition) female genital vulva pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pn NZ AJCC (8th edition) female genital vulva pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-pt NZ AJCC (8th edition) female genital vulva pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-female-genital-vulva-stage-group NZ AJCC (8th edition) female genital vulva stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-clinical-stage-group NZ AJCC (8th edition) gastrointestinal clinical stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-cn NZ AJCC (8th edition) gastrointestinal colon and rectum clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-ct NZ AJCC (8th edition) gastrointestinal colon and rectum clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pm NZ AJCC (8th edition) gastrointestinal colon and rectum pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pn NZ AJCC (8th edition) gastrointestinal colon and rectum pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-pt NZ AJCC (8th edition) gastrointestinal colon and rectum pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-colorectal-stage-group NZ AJCC (8th edition) gastrointestinal colon and rectum stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pathological-stage-group NZ AJCC (8th edition) gastrointestinal pathological stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pn NZ AJCC (8th edition) gastrointestinal pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-pt NZ AJCC (8th edition) gastrointestinal pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gi-yp-stage-group NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-cn NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-ct NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pm NZ AJCC (8th edition) gastrointestinal stromal tumour pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pn NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-gist-pt NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cm NZ AJCC (8th edition) haematology clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-cn NZ AJCC (8th edition) haematology clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-ct NZ AJCC (8th edition) haematology clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-hl-or-nhl-stage-group NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cm NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-cn NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-ct NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pm NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pn NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-mf-or-ss-pt NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-cm NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-ct NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pm NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pt NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-paed-hl-stage-group NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pcm-stage-group NZ AJCC (8th edition) haematology plasma cell myeloma stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-pn NZ AJCC (8th edition) haematology pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-haematology-stage-group NZ AJCC (8th edition) haematology stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-cn NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cm NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cn NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pm NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pt NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pm NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pn NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-pt NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-neuroendocrine-gi-stage-group NZ AJCC (8th edition) neuroendocrine gastrointestinal stage groupactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-cm NZ AJCC (8th edition) thoracic clinical M categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-ct NZ AJCC (8th edition) thoracic lung clinical T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pn NZ AJCC (8th edition) thoracic lung pathological N categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-pt NZ AJCC (8th edition) thoracic lung pathological T categoryactive2024-11sct
tewhatuora.nzhtsR4https://nzhts.digital.health.nz/fhir/ValueSet/canshare-tnm8-thoracic-lung-stage-group NZ AJCC (8th edition) thoracic lung stage groupactive2024-11sct

XIG built as of 17 Dec 2024. Found 40236 resources in 710 packages.